Matt is a pharmacologist, board certified toxicologist and Fellow of the Academy of Toxicological Sciences. He has over 23+ years of experience in inhaled and intranasal drug development having supported formulation and device feasibility, in vitro-animal-human dose translation, pharmacology/ animal models of respiratory disease, ADME/PK/PD, regulatory toxicology, domestic and international regulatory filings, and early-phase clinical trials. Dr. Reed has supported technologies ranging from small molecules, peptides, proteins, oligonucleotides, lipid nanoparticle gene delivery, and antibodies to conjugate-based platforms, etc.
Dr. Reed was formerly Vice President of Applied Toxicology and Nonclinical Development, Director of Preclinical Drug Development, and a Senior Scientist at Lovelace Biomedical. In additional to general respiratory consulting, Matt currently serves as CSO of Nob Hill Therapeutics and in senior management (consulting) roles at Rage Biotherapeutics and Kinnear Pharmaceuticals.